Breaking News

Piramal Critical Care, Medivant Enter Strategic Injectables Alliance

Aims to address the shortage of injectable drugs in hospitals across the U.S. or COVID-19 patients.

By: Contract Pharma

Contract Pharma Staff

Piramal Critical Care (PCC) entered a strategic partnership with U.S.-based pharmaceutical outsourcing facility, Medivant Healthcare, to help address the shortage of injectable drugs in hospitals across the U.S. Through this partnership, PCC and Medivant Healthcare will work to distribute single-dose injectable drugs in approved states for COVID-19 patients that have fallen short in supply. Peter DeYoung, Chief Executive Officer, Piramal Critical Care, said, “In the last few months...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters